VP non-clinical and clinical bioanalysis
Regeneron
Tarrytown, New York
Boris Gorovits earned a Ph.D. in Enzymology from the Moscow State University, later completed postdoctoral research studies in Protein biophysics at the Medical Center, U of Texas at SA. Boris’s industry experience includes working at Regeneron, Wyeth and Pfizer, mainly focusing on bioanalytical support and immunogenicity of various modalities of biotherapeutics, support of discovery and regulated non-clinical and clinical studies. While at Pfizer, Boris co-chaired company-wide Immunogenicity Expert Working Group. Recently Boris has been involved in support of Gene and Cell therapy modalities. At Regeneron, Boris leads Non-clinical and Clinical Bioanalysis teams with the focus on developing and applying various assays designed in support of a diverse biotherapeutic portfolio of the company. Boris is actively involved in industry conversations focusing on PK and immunogenicity assessments of various modalities, including gene therapy and CAR-T.
Disclosure information not submitted.
Keynote: Purposeful Bioanalysis: Ask the Why and What Questions
Tuesday, October 22, 2024
1:30 PM – 2:30 PM MT